Dr. Chan noted, "If our technology works the way we hope it does, then it has the potential to be a blockbuster product. That can impact the top and bottom lines of most strategic partners. We believe we have a product that has little competition, a big market with unmet needs, technology attractive to strategic partners, and a solid, profitable business model."
If MedaSorb meets its goals, it will not only be attractive to strategic partners, but to prospective shareholders as well.